Viewing nowCMG Losartan Tablets (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

MFDS item code 201310778 · Approved 2013.12.19
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
This medication is used to treat hypertension, and is particularly effective in patients with hypertension and kidney disease due to type 2 diabetes. It helps manage blood pressure to stabilize it and slows the progression of kidney disease. Therefore, it is used for blood pressure control and kidney protection.
This drug may be taken regardless of meals, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily or, if needed, increased up to 100 mg once daily. 3) If blood pressure is not controlled with this drug alone, it may be coadministered with another antihypertensive drug (e.g., a low-dose diuretic). An additive effect has been observed with coadministration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this drug once daily. Depending on blood pressure, the dose may be increased up to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be coadministered with insulin and commonly used hypoglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). 3. Special patient groups 1) Elderly patients No adjustment of the initial dose is required in elderly patients aged 75 years or younger. For patients older than 75 years, an initial dose of 25 mg of this drug once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is required. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. 3) Patients with intravascular volume depletion An initial dose of 25 mg of this drug once daily is recommended for patients who may have intravascular volume depletion (e.g., patients receiving diuretic treatment) (see Precautions for Use). 4) Patients with hepatic impairment Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years and older who weigh 20 kg or more but less than 50 kg and can swallow tablets: The recommended dose is 25 mg of this drug once daily, which may be increased up to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily, which may be increased up to a maximum of 100 mg once daily according to the patient's blood pressure response. Not recommended for children younger than 6 years, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.
This drug can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued as soon as pregnancy is confirmed. Women who are pregnant or may become pregnant should not use this medication. Patients with severely impaired liver function or certain genetic disorders should not take this medication. Patients with a history of angioedema or certain heart valve diseases should also exercise caution. Elderly patients, those with hyperkalemia, and patients with mild to moderate liver dysfunction should use this medication cautiously as there is a risk of rapid blood pressure drop. This drug is generally well tolerated, but side effects such as dizziness, muscle cramps, back pain, and upper respiratory infections may occur. Rarely, serious adverse reactions such as angioedema, liver function abnormalities, rhabdomyolysis, and hyperkalemia may occur, so patients should consult a doctor immediately if any unusual symptoms arise. This medication may interact with other drugs; caution is advised when taken with potassium-sparing diuretics or potassium supplements, certain anti-inflammatory pain relievers, and lithium. In particular, grapefruit juice may reduce the effectiveness of this drug, so it should be avoided during treatment. It is advisable for pregnant and nursing women to avoid this medication, and if it must be used, consultation with a specialist is necessary. It should not be given to children, especially those under 6 years old or children with severely impaired kidney function. In the case of overdose, symptoms of low blood pressure and tachycardia may occur, requiring immediate treatment, and this drug is not removed by dialysis. During treatment, regular checks of blood pressure, kidney function, and electrolyte levels in the blood are necessary, and patients should consult healthcare professionals immediately if any unusual symptoms appear. Additionally, there may be dizziness or drowsiness due to blood pressure reduction, so caution should be exercised while driving or operating machinery. This medication should be kept out of reach of children and should not be transferred to another container for safety purposes.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. Also, it should be stored at room temperature between 1 to 30 degrees Celsius, away from extreme cold or heat.
White oval film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.